−0.39SEK
−4.74 MSEK
17.50 MSEK
11.13 M
About INHALATION SCIENCES SWEDEN AB
Sector
Industry
CEO
Manoush Masarrat
Website
Headquarters
Huddinge
Founded
2004
ISIN
SE0009983893
FIGI
BBG00HL45RZ7
Inhalation Sciences Sweden AB develops and sells patented, labtech equipment for inhalation research. Its products include PreciseInhale, which is an advanced laboratory system that lets scientists measure how inhaled particles act in lungs and affect health; LaminarPace which is a patented tool for drying small amounts of drug substance with very low levels of wastage. The company was founded by Per Magnus Gerde in 2005 and is headquartered in Huddinge, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ISAB is 3.67 SEK — it has decreased by 1.34% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange INHALATION SCIENCES SWEDEN AB stocks are traded under the ticker ISAB.
ISAB stock is 17.35% volatile and has beta coefficient of 0.13. Check out the list of the most volatile stocks — is INHALATION SCIENCES SWEDEN AB there?
INHALATION SCIENCES SWEDEN AB revenue for the last quarter amounts to 3.40 M SEK despite the estimated figure of 6.40 M SEK. In the next quarter revenue is expected to reach 7.20 M SEK.
Yes, you can track INHALATION SCIENCES SWEDEN AB financials in yearly and quarterly reports right on TradingView.
ISAB stock has risen by 15.41% compared to the previous week, the month change is a 5.16% rise, over the last year INHALATION SCIENCES SWEDEN AB has showed a 10.54% increase.
ISAB net income for the last quarter is −903.00 K SEK, while the quarter before that showed −1.31 M SEK of net income which accounts for 30.80% change. Track more INHALATION SCIENCES SWEDEN AB financial stats to get the full picture.
Today INHALATION SCIENCES SWEDEN AB has the market capitalization of 56.42 M, it has decreased by 0.62% over the last week.
No, ISAB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ISAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INHALATION SCIENCES SWEDEN AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INHALATION SCIENCES SWEDEN AB technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INHALATION SCIENCES SWEDEN AB stock shows the sell signal. See more of INHALATION SCIENCES SWEDEN AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on INHALATION SCIENCES SWEDEN AB future price: according to them, ISAB price has a max estimate of 16.50 SEK and a min estimate of 16.50 SEK. Read a more detailed INHALATION SCIENCES SWEDEN AB forecast: see what analysts think of INHALATION SCIENCES SWEDEN AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INHALATION SCIENCES SWEDEN AB EBITDA is −2.75 M SEK, and current EBITDA margin is −23.14%. See more stats in INHALATION SCIENCES SWEDEN AB financial statements.